Financial Performance - The company's revenue for Q3 2024 reached ¥349,788,836.26, representing a year-on-year increase of 1.56%[3] - Net profit attributable to shareholders was ¥45,521,329.00, up 9.17% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥37,212,872.22, reflecting a 6.58% increase year-on-year[3] - Total operating revenue for Q3 2024 reached CNY 1,052,921,002.65, an increase of 4.9% compared to CNY 1,011,248,393.47 in Q3 2023[12] - Net profit for Q3 2024 was CNY 117,937,732.55, representing a 9.5% increase from CNY 107,667,337.93 in the same period last year[13] - Earnings per share for Q3 2024 were CNY 0.6850, slightly up from CNY 0.6822 in Q3 2023[13] Cash Flow and Investments - The net cash flow from operating activities for the year-to-date period was ¥160,069,795.09, showing a significant increase of 68.30%[3] - Operating cash inflow totaled CNY 1,311,305,143.09, an increase from CNY 1,176,763,138.93 in the previous period, representing a growth of approximately 11.4%[15] - Cash inflow from investment activities amounted to CNY 903,267,724.15, compared to CNY 440,712,329.76 in the prior period, reflecting a growth of 105.5%[15] - The company experienced a 96.02% increase in cash recovered from investments, amounting to ¥833,000,000.00, due to the maturity of structured deposits[6] - The company reported a 257.63% increase in cash received related to investment activities, totaling ¥51,700,000.00, driven by an increase in matured time deposits[6] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,950,919,260.14, an increase of 4.39% from the end of the previous year[3] - The total liabilities as of Q3 2024 were CNY 539,627,586.57, an increase from CNY 463,579,915.98 in Q3 2023, indicating a rise of 16.4%[12] - The company's cash and cash equivalents decreased from 533,602,642.64 to 386,409,832.70, a decline of approximately 27.5%[10] - The total current assets increased from 1,583,649,100.62 to 1,662,083,051.91, representing a growth of about 4.96%[10] - The company's inventory rose from 189,184,071.93 to 243,832,858.08, an increase of approximately 28.9%[10] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 16,646[7] - The largest shareholder, Chongqing Light Textile Holdings Group Co., Ltd., holds 59.83% of the shares, totaling 103,012,300 shares[7] Research and Development - Research and development expenses increased to CNY 38,366,160.95, compared to CNY 33,257,379.34 in the previous year, marking a growth of 15.9%[12] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[12]
登康口腔(001328) - 2024 Q3 - 季度财报